Home
>
National Drug Code (NDC)
>
Diflunisal
Diflunisal - 55289-460-20 - (Diflunisal)
Drug Information of Diflunisal
| Product NDC: | 55289-460 |
| Proprietary Name: | Diflunisal |
| Non Proprietary Name: | Diflunisal |
| Active Ingredient(s): | 500 mg/1 & nbsp; Diflunisal |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Diflunisal
| Product NDC: | 55289-460 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA073673 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100820 |
Package Information of Diflunisal
| Package NDC: | 55289-460-20 |
| Package Description: | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-460-20) |
NDC Information of Diflunisal
| NDC Code | 55289-460-20 |
| Proprietary Name | Diflunisal |
| Package Description | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-460-20) |
| Product NDC | 55289-460 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Diflunisal |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20100820 |
| Marketing Category Name | ANDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | DIFLUNISAL |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
